Shenzhen Chipscreen Biosciences Co., Ltd. (SHSE: 688321)
Health Care · Pharmaceuticals · CN
CN¥27.95
-9.40% today · -27.4% 1Y
Shenzhen Chipscreen Biosciences Co., Ltd. (SHSE: 688321) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $1.84B and employs 1,002 people.
Over the last twelve months the share price has lost 27.4%, trading between 23.41 and 39.69.
Tweenvest scores Shenzhen Chipscreen Biosciences Co., Ltd. across four factors: quality 68/100, value 30/100, growth 100/100, dividend 4/100. Its strongest factor is growth.
688321 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.84B
- Revenue (TTM)
- $154.09M
- P/E
- 126.82
- EPS
- 0.22
- Dividend yield
- 0.21%
- Beta (5Y)
- 0.65
- 52-week high
- CN¥39.69
- 52-week low
- CN¥23.41
- Avg volume (3M)
- —
- Shares outstanding
- 442.34M
- Employees
- 1,002
- Next earnings
- —
About Shenzhen Chipscreen Biosciences Co., Ltd.
Established in 2001 and headquartered in Shenzhen, China, Chipscreen Biosciences specializes in the discovery, development, and commercialization of innovative small-molecule pharmaceuticals. The company cultivates a pipeline of novel drug candidates and precursor compounds, all of which are progressing through diverse research phases and are protected by extensive global intellectual property rights. Its key therapeutic areas of focus encompass oncology, metabolic disorders, and autoimmune conditions.
- ISIN
- CNE100003LW0
- Founded
- 2001
- Listed since
- Aug 12, 2019
- Exchange
- Shanghai Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,255.40 | +0.88% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $270.24 | +1.07% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $152.55 | +2.39% |
| Roche Holding AGSWX: ROP | $373.91B | CHF375.60 | +1.02% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £122.40 | +1.26% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $28.07 | +1.01% |
Figures last refreshed Aug 18, 2026.